Mark Hopman - Chief Commercial Officer at Beta Bionics, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Mark Hopman in Beta Bionics, Inc.

Buys

Open market
Shares
Avg price
Total value

Sells

Open market
Shares
-86,118
Avg price
$18.99
Total value
-$1,635,575

Net

Past year
Shares
-86,118
Share %
-100%
Total value
-$1,635,575

Reported holdings for Mark Hopman in Beta Bionics, Inc.

Form 4 holding Chief Commercial Officer

Beta Bionics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
20,950
Estimated value
Report date
16 Nov 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Mark Hopman in Beta Bionics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .